FUTASONE

Each gram contains: Fusidic acid 20 mg, betamethasone (as valerate) 1 mg.

Indications

It is indicated in inflammatory dermatoses where bacterial infection is present or like­ ly to occur. Inflammatory dermatoses include atopic eczema, discoid eczema, stasis eczema, seborrheic dermatitis, con­tact dermatitis, lichen simplex chronicus, psoriasis (including scalp psoriasis), and discoid lupus erythematosus.

NOTE:

It should be avoided in widespread plague psoriasis and in flexural and facial psoriasis.

Contraindication

Hypersensitivity reactions to any of its com­ponents. It is also contraindicated in the presence of untreated viral, tuberculosis, or fungal skin infection; rosacea (acne rosacea); perioral dermatitis; acne vulgaris; leg ulcers. It should not be used for infants under 1 year (see Precautions).

Side Effects

Infrequently, some adverse reactions may occur with topical corticosteroids especially with the use of occlusive dressings. These include thinning of the skin which may be restored over a period of time after com­pleting the treatment, striae, telangiectasia (dilation of the superficial blood vessels), contact dermatitis, mild depigmentation, or acne at the site of application. Very rarely, local hypersensitivity reactions
may occur.

Precautions

As with other preparations containing topi­cal corticosteroids, Futasone cream should not be used on the face unless absolutely indicated.
Prolonged treatment with topical corticos­teroids increases the possibility of systemic absorption especially when applied to extensive areas or under occlusive dress­ings, particularly in children.

Children: Futasone cream is contraindicated in infants under 1 year; in general, potent topical corticosteroids are belter to be avoided in pediatric treatment or. if neces­sary. used with great care for short periods.

Pregnancy and Lactation

See insert leaflet.

Application

Apply a small amount to the affected area 1 • 2 times daily, generally for a penod of 7days.

NOTE:

When desired, the area treated canbe covered with a dressing, but a less fre­quent application may be adequate.

Packaging

cr: 15 g.